drugset
drugset / Trial / NCT01423708

Everolimus in de Novo Liver Transplantation: a Multicentre Randomized Study

NCT01423708 ↗

Phase 2 Unknown 117 enrolled Azienda Ospedaliera di Padova
RandomizedParallel-groupOpen-labelTreatment

Summary

Safety and Efficacy of Everolimus in adult de novo liver transplant recipients.

Timeline

Start
2010-02
Primary completion
2014-01
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Everolimus Small molecule — —

Indications

cirrhosis of liver liver and intrahepatic bile duct neoplasm liver failure